Dora Ho
Academic Appointments
- Clinical Assistant Professor, Medicine - Infectious Diseases
Key Documents
Contact Information
-
Clinical Offices
Division of Infectious Diseases 300 Pasteur DR Lane Bldg Room L 135 Stanford, CA 94305 Tel Work (650) 736-2442 Fax (650) 723-3474
Professional Overview
Clinical Focus
- Infectious Disease
- Infectious Diseases
- Immunocompromised Host
Administrative Appointments
- Chair, Antibiotic Subcommittee (2009 - present)
- Clinical Chief, Div of Infectious Diseases (2010 - present)
Honors and Awards
- Postdoctoral Fellowship, Huntingtons Disease Society of America (1991-1993)
- Morris Alex, M.D. Prize for clinical medicine, Washington University School of Medicine (1999)
- Dr. Lee B. & Virginia G. Harrison Scholarship for internal medicine, Washington University School of Medicine (1999 & 2000)
- Gene transfer using herpes virus vectors as a tool for neuroprotection, US Patent No: 5661033 (1997)
Professional Education
| Board Certification: | Infectious Disease, American Board of Internal Medicine (2005) |
| Medical Education: | Washington University in St. Louis MO (2001) |
| Fellowship: | Stanford University Medical Center CA (2005) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (2004) |
| Residency: | Santa Clara Valley Medical Center, CA USA (2003) |
| MD: | Washington University, St. Louis (2001) |
Graduate & Fellowship Program Affiliations
Scientific Focus
Current Research Interests
Dr. Ho did her PhD work in HSV pathogenesis and postdoctoral research in CNS gene therapy with viral vectors. Her current interests are in viral and fungal infections in immunocompromised patients and her research focuses on infection complications in neutropenic patients. In collaboration with Dr. C. Dekker of the Stanford-LPCH Vaccine Program and with Dr. J. Brown of the BMT Division, she is also conducting clinical trials on vaccines, antivirals and antifungals as a co-investigator.
Clinical Trials
- Not Recruiting An Observational Study of Fungal Biomarkers (MK-0000-089 AM3)
- Not Recruiting A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED)
- Not Recruiting Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients
- Not Recruiting Sanofi H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations
- Not Recruiting A Study of an Investigational V212/Heat-Treated VZV Vaccine in Immunocompromised Adults
Publications
- Clinical significance of low cytomegalovirus DNA levels in human plasma. J Clin Microbiol. 2012; (7): 2378-83
- Brain abscess caused by Phaeoacremonium parasiticum in an immunocompromised patient. J Clin Microbiol. 2011; (3): 1171-4
- Early CMV viremia is associated with impaired viral control following nonmyeloablative hematopoietic cell transplantation with a total lymphoid irradiation and antithymocyte globulin preparative regimen. Biol Blood Marrow Transplant. 2011; (5): 693-702
- Treatment of acyclovir-resistant herpes simplex virus with continuous infusion of high-dose acyclovir in hematopoietic cell transplant patients. Biol Blood Marrow Transplant. 2011; (2): 259-64
- Yield of diagnostic procedures for invasive fungal infections in neutropenic febrile patients with chest computed tomography abnormalities. Mycoses. 2011; (1): 59-70
- Varicella Zoster Virus In: Yu VL, Weber R, Raoult D (eds.), Antinicrobial Therapy and Vaccines 3rd edition. 2009
Help